In 2021, it was approved as a once weekly injection for chronic weight management in adults and kids down to age 12 as Wegovy
Research-grade Semaglutide is manufactured for in-vitro and preclinical laboratory use only, not under GMP pharmaceutical regulations required for human drugs like Ozempic or Wegovy
Our experience shows that even the most perfectly reconstituted peptide can degrade rapidly if not stored correctly
Working with a trusted provider is the best way to minimize risks and get the results you want
Population (P): Adults (19 years), both males and females, either healthy or diagnosed with chronic metabolic or inflammatory conditions (e.g., type 2 diabetes, polycystic ovary syndrome, obesity, cardiovascular diseases, arthritis, or ocular disorders)